Cargando…
2521. VE707, a Defined Live Biotherapeutic Product for Prevention of Infection by Multidrug-Resistant Gram-Negative Bacteria
BACKGROUND: Infections with multidrug-resistant organisms (MDRO) are increasing at an alarming rate in hospitals worldwide. MDRO infections are often preceded by asymptomatic intestinal colonization and growth by the MDRO. Treatments such as non-absorbable antibiotics and fecal microbiota transplant...
Autores principales: | Medlock, Gregory, Felix, Cintia, Alsharif, Wajd, Cornacchione, Lou, Schinn, Matthew, Watson, Andrea, Bedard-Shurtleff, Suzanne, Norman, Jason, Faith, Jeremiah, Kuijper, Ed J, Olle, Bernat, Caballero, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677003/ http://dx.doi.org/10.1093/ofid/ofad500.2139 |
Ejemplares similares
-
PB2521: STUDY OF HEMOGLOBIN S-OMAN TRAIT: NEW INSIGHTS
por: Al-Mahrouqi, Nouh, et al.
Publicado: (2023) -
2140. Biological Features of Response to VE303, a Defined Bacterial Consortium, in Patients with Clostridioides difficile Infection (CDI): Results from the Phase 2 CONSORTIUM Study
por: Menon, Rajita, et al.
Publicado: (2023) -
No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirin
por: Frey, Reiner, et al.
Publicado: (2011) -
2521. The Potential Rise in the Incidence of Rotavirus G3P[8] in Kuwait
por: Al-Nakib, Widad Widad, et al.
Publicado: (2018) -
Structural insights into functional amyloid inhibition in Gram −ve bacteria
por: Hawthorne, William, et al.
Publicado: (2016)